Your browser doesn't support javascript.
loading
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Tasçi, Elif Senocak; Oyan, Basak; Sönmez, Özlem; Mutlu, Arda Ulas; Atci, Muhammed Mustafa; Sakin, Abdullah; Öner, Irem; Çinkir, Havva Yesil; Eryilmaz, Melek Karakurt; Çaglayan, Dilek; Balçik, Onur Yazdan; Paksoy, Nail; Karabulut, Senem; Salim, Derya Kivrak; Bilir, Cemil; Özen, Miraç; Özçelik, Melike; Arican, Ali; Akagündüz, Baran; Inal, Ali; Aydin, Dinçer; Özer, Leyla; Gülmez, Ahmet; Turhal, Nazim Serdar; Esen, Selin Aktürk; Algin, Efnan; Akbas, Sinem; Iriagaç, Yakup; Sakalar, Teoman; Ünal, Çaglar; Er, Özlem; Seçmeler, Saban; Bozkurt, Mustafa.
Affiliation
  • Tasçi ES; Department of Medical Oncology, Saglik Bilimleri University, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Turkey. esenocak@gmail.com.
  • Oyan B; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Sönmez Ö; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Mutlu AU; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Atci MM; Department of Medical Oncology, Haseki Education and Research Hospital, Istanbul, Turkey.
  • Sakin A; Department of Medical Oncology, Medipol Bahçelievler Hospital, Istanbul, Turkey.
  • Öner I; Department of Medical Oncology, Konya City Hospital, Konya, Turkey.
  • Çinkir HY; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
  • Eryilmaz MK; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey.
  • Çaglayan D; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey.
  • Balçik OY; Department of Medical Oncology, Mardin Education and Research Hospital, Mardin, Turkey.
  • Paksoy N; Department of Medical Oncology, Tekirdag Dr. Ismail Fehmi Cumalioglu City Hospital, Tekirdag, Turkey.
  • Karabulut S; Department of Medical Oncology, Sisli Kolan Hospital, Istanbul, Turkey.
  • Salim DK; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey.
  • Bilir C; Department of Medical Oncology, Medical Park Hospital, Istanbul, Turkey.
  • Özen M; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey.
  • Özçelik M; Department of Medical Oncology, University of Health Sciences Umraniye Education and Research Hospital, Istanbul, Turkey.
  • Arican A; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Akagündüz B; Department of Medical Oncology, Binali Yildirim University, Erzincan, Turkey.
  • Inal A; Department of Medical Oncology, Mersin City Hospital, Mersin, Turkey.
  • Aydin D; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey.
  • Özer L; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Gülmez A; Department of Medical Oncology, Adana City Hospital, Adana, Turkey.
  • Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
  • Esen SA; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Algin E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Akbas S; Department of Medical Oncology, Koç University Hospital, Istanbul, Turkey.
  • Iriagaç Y; Department of Medical Oncology, Namik Kemal University, Tekirdag, Turkey.
  • Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey.
  • Ünal Ç; Department of Medical Oncology, Bilim University, Istanbul, Turkey.
  • Er Ö; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
  • Seçmeler S; Department of Medical Oncology, Medical Park Bahçelievler Hospital, Istanbul, Turkey.
  • Bozkurt M; Department of Medicine, Acibadem MAA University, Istanbul, Turkey.
BMC Cancer ; 24(1): 114, 2024 Jan 23.
Article in En | MEDLINE | ID: mdl-38262962